Loading...
Fennec Pharmaceuticals Inc.
FENC•NASDAQ
HealthcareBiotechnology
$8.43
$0.53(6.71%)
Fennec Pharmaceuticals Inc. (FENC) Financial Performance & Statements
Review Fennec Pharmaceuticals Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
123.69%
↑ 123.69%
Operating Income Growth
120.11%
↑ 120.11%
Net Income Growth
97.28%
↑ 97.28%
Operating Cash Flow Growth
257.38%
↑ 257.38%
Operating Margin
-38.76%
↓ 38.76%
Gross Margin
90.27%
↑ 90.27%
Net Profit Margin
-45.52%
↓ 45.52%
ROE
589.85%
↑ 589.85%
ROIC
-31.51%
↓ 31.51%
Fennec Pharmaceuticals Inc. (FENC) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Fennec Pharmaceuticals Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $7.92M | $6.97M | $7.26M | $25.38M |
| Cost of Revenue | $669000.00 | $1.36M | $608000.00 | $550000.00 |
| Gross Profit | $7.26M | $5.62M | $6.65M | $24.83M |
| Gross Profit Ratio | $0.92 | $0.81 | $0.92 | $0.98 |
| R&D Expenses | $50000.00 | $97000.00 | $157000.00 | $3000.00 |
| SG&A Expenses | $8.14M | $10.72M | $11.54M | $11.08M |
| Operating Expenses | $8.19M | $10.82M | $11.69M | $11.08M |
| Total Costs & Expenses | $8.86M | $12.18M | $12.30M | $11.63M |
| Interest Income | $374000.00 | $516000.00 | $570000.00 | $197000.00 |
| Interest Expense | $966000.00 | $1.02M | $1.04M | $1.03M |
| Depreciation & Amortization | $26000.00 | $25000.00 | $26000.00 | $723000.00 |
| EBITDA | -$909000.00 | -$4.68M | -$4.48M | $14.59M |
| EBITDA Ratio | -$0.11 | -$0.67 | -$0.62 | $0.58 |
| Operating Income | -$934000.00 | -$5.20M | -$5.04M | $13.74M |
| Operating Income Ratio | -$0.12 | -$0.75 | -$0.69 | $0.54 |
| Other Income/Expenses (Net) | -$685000.00 | -$533000.00 | -$514000.00 | -$906000.00 |
| Income Before Tax | -$1.62M | -$5.74M | -$5.55M | $12.84M |
| Income Before Tax Ratio | -$0.20 | -$0.82 | -$0.76 | $0.51 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.62M | -$5.74M | -$5.55M | $12.84M |
| Net Income Ratio | -$0.20 | -$0.82 | -$0.76 | $0.51 |
| EPS | -$0.06 | -$0.21 | -$0.20 | $0.47 |
| Diluted EPS | -$0.06 | -$0.21 | -$0.20 | $0.41 |
| Weighted Avg Shares Outstanding | $27.46M | $27.37M | $27.30M | $27.05M |
| Weighted Avg Shares Outstanding (Diluted) | $27.46M | $27.37M | $27.30M | $31.09M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan